WELCOME TO THE WEBSITE OF MAGNA PLATINA LIMITED
WELCOME TO THE WEBSITE OF MAGNA PLATINA LIMITED
We use nanotechnology to develop: multimodal, biocompatible and disease-state targeted, contrast agents for imaging across MRI, CT, PET and ultrasound.
ProSense, our multimodal imaging technology is capable of developing state-of-the-art facilities to accelerate: the diagnosis and the initiation of treatments across some of the most deadly diseases.
Our formulation chemists are developing injectables that eliminate the long-term adverse effects of gadolinium and iodine based contrast agents. The injectables will make contrast imaging a safer and more sustainable procedure.
Copyright © 2024 Magna Platina Ltd - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.